相似文献
1
Genetic profiteering.
Nat Biotechnol. 2006 Aug;24(8):888-90. doi: 10.1038/nbt0806-888. Epub 2006 Aug 3.
2
Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.
Oklahoma Law Rev. 2004 Summer;57(2):251-302.
3
[Not Available].
Rev Med Suisse. 2017 May 17;13(563):1067.
4
Truth in testing laws: a shot in the arm for designer gene tests.
Health Matrix Clevel. 2006 Summer;16(2):797-829.
5
The evidence dilemma and cultural change.
Health Aff (Millwood). 2009 May-Jun;28(3):925-6; author reply 926-7. doi: 10.1377/hlthaff.28.3.925-b.
6
7
In search of a coherent framework: options for FDA oversight of genetic tests.
Food Drug Law J. 2007;62(4):617-52.
8
[More controversies about direct-to-consumer genetic profiles].
Med Sci (Paris). 2014 Mar;30(3):227-8. doi: 10.1051/medsci/20143003001. Epub 2014 Mar 31.
9
Reports on the potential dangers of genetic tests sold direct to the public.
Hum Reprod Genet Ethics. 2003;9(2):21-2.
10
Re-framing the discussion: commercial genetic testing in Canada.
Health Law J. 1999;7:49-67.
Zotero 插件